These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

444 related articles for article (PubMed ID: 33927214)

  • 1. Alantolactone inhibits cervical cancer progression by downregulating BMI1.
    Sun X; Xu H; Dai T; Xie L; Zhao Q; Hao X; Sun Y; Wang X; Jiang N; Sang M
    Sci Rep; 2021 Apr; 11(1):9251. PubMed ID: 33927214
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aberrantly elevated Bmi1 promotes cervical cancer tumorigenicity and tumor sphere formation via enhanced transcriptional regulation of Sox2 genes.
    Xu R; Chen L; Yang WT
    Oncol Rep; 2019 Aug; 42(2):688-696. PubMed ID: 31173263
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alantolactone exhibits selective antitumor effects in HELA human cervical cancer cells by inhibiting cell migration and invasion, G2/M cell cycle arrest, mitochondrial mediated apoptosis and targeting Nf-kB signalling pathway.
    Zhang Y; Zhao Y; Ran Y; Guo J; Cui H; Liu S
    J BUON; 2019; 24(6):2310-2315. PubMed ID: 31983099
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alantolactone Induced Apoptosis and DNA Damage of Cervical Cancer through ATM/CHK2 Signaling Pathway.
    Zhang Y; Li H; Wei Y; Li L
    Biol Pharm Bull; 2024; 47(7):1255-1264. PubMed ID: 38972750
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Resveratrol suppresses the growth and metastatic potential of cervical cancer by inhibiting STAT3
    Sun X; Xu Q; Zeng L; Xie L; Zhao Q; Xu H; Wang X; Jiang N; Fu P; Sang M
    Cancer Med; 2020 Nov; 9(22):8685-8700. PubMed ID: 33040485
    [TBL] [Abstract][Full Text] [Related]  

  • 6. BMI‑1 promotes invasion and metastasis in endometrial adenocarcinoma and is a poor prognostic factor.
    Yu J; Chen L; Bao Z; Liu Y; Liu G; Li F; Li L
    Oncol Rep; 2020 May; 43(5):1630-1640. PubMed ID: 32323819
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alantolactone selectively suppresses STAT3 activation and exhibits potent anticancer activity in MDA-MB-231 cells.
    Chun J; Li RJ; Cheng MS; Kim YS
    Cancer Lett; 2015 Feb; 357(1):393-403. PubMed ID: 25434800
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CSC-3436 inhibits TWIST-induced epithelial-mesenchymal transition via the suppression of Twist/Bmi1/Akt pathway in head and neck squamous cell carcinoma.
    Lai YJ; Yu WN; Kuo SC; Ho CT; Hung CM; Way TD; Chen CT
    J Cell Physiol; 2019 Jun; 234(6):9118-9129. PubMed ID: 30341909
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting MCL1 with Sanggenon C overcomes MCL1-driven adaptive chemoresistance via dysregulation of autophagy and endoplasmic reticulum stress in cervical cancer.
    Sun W; Cai H; Zhang K; Cui H; Zhao E
    Phytomedicine; 2024 Oct; 133():155935. PubMed ID: 39126925
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Knockdown of hnRNP A2/B1 inhibits cell proliferation, invasion and cell cycle triggering apoptosis in cervical cancer via PI3K/AKT signaling pathway.
    Shi X; Ran L; Liu Y; Zhong SH; Zhou PP; Liao MX; Fang W
    Oncol Rep; 2018 Mar; 39(3):939-950. PubMed ID: 29328485
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alantolactone sensitizes human pancreatic cancer cells to EGFR inhibitors through the inhibition of STAT3 signaling.
    Zheng H; Yang L; Kang Y; Chen M; Lin S; Xiang Y; Li C; Dai X; Huang X; Liang G; Zhao C
    Mol Carcinog; 2019 Apr; 58(4):565-576. PubMed ID: 30520143
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Knockdown BMI1 expression inhibits proliferation and invasion in human bladder cancer T24 cells.
    Liang W; Zhu D; Cui X; Su J; Liu H; Han J; Zhao F; Xie W
    Mol Cell Biochem; 2013 Oct; 382(1-2):283-91. PubMed ID: 23820733
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vorinostat targets UBE2C to reverse epithelial-mesenchymal transition and control cervical cancer growth through the ubiquitination pathway.
    Pan B; Yin S; Peng F; Liu C; Liang H; Su J; Hsiao WLW; Cai Y; Luo D; Xia C
    Eur J Pharmacol; 2021 Oct; 908():174399. PubMed ID: 34331954
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of Growth of Esophageal Cancer by Alantolactone via Wnt/β- Catenin Signaling.
    Wang Z; Hu Q; Chen H; Shi L; He M; Liu H; Li T; Lü M; Deng M; Luo G
    Anticancer Agents Med Chem; 2021; 21(18):2525-2535. PubMed ID: 33438562
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitative proteomics analysis of differentially expressed proteins induced by astragaloside IV in cervical cancer cell invasion.
    Xia C; He Z; Cai Y
    Cell Mol Biol Lett; 2020; 25():25. PubMed ID: 32265995
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of the epithelial to mesenchymal transition and metastasis by Raf kinase inhibitory protein-dependent Notch1 activity.
    Noh HS; Hah YS; Ha JH; Kang MY; Zada S; Rha SY; Kang SS; Kim HJ; Park JY; Byun JH; Hahm JR; Shin JK; Jeong SH; Lee YJ; Kim DR
    Oncotarget; 2016 Jan; 7(4):4632-46. PubMed ID: 26716415
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Bcl-2 associated athanogene 3 affects the epithelial-mesenchymal transition in human cervical cancer].
    Wei L; Qin XP; Zhao XX; Wang W
    Zhonghua Fu Chan Ke Za Zhi; 2017 Aug; 52(8):551-557. PubMed ID: 28851173
    [No Abstract]   [Full Text] [Related]  

  • 18. PTC209, a Specific Inhibitor of BMI1, Promotes Cell Cycle Arrest and Apoptosis in Cervical Cancer Cell Lines.
    Li J; Vangundy Z; Poi M
    Anticancer Res; 2020 Jan; 40(1):133-141. PubMed ID: 31892561
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bmi1 enhances tumorigenicity and cancer stem cell function in pancreatic adenocarcinoma.
    Proctor E; Waghray M; Lee CJ; Heidt DG; Yalamanchili M; Li C; Bednar F; Simeone DM
    PLoS One; 2013; 8(2):e55820. PubMed ID: 23437065
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alantolactone exhibits antiproliferative and apoptosis-promoting properties in colon cancer model via activation of the MAPK-JNK/c-Jun signaling pathway.
    Ren Y; Lv C; Zhang J; Zhang B; Yue B; Luo X; Yu Z; Wang H; Ren J; Wang Z; Dou W
    Mol Cell Biochem; 2021 Dec; 476(12):4387-4403. PubMed ID: 34460036
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.